Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.

× No keyword cloud information.

75 in total

1. A case report on the use of recombinant hirudin as an anticoagulant for cardiopulmonary bypass in open heart surgery.

Authors: F C Riess; B Pötzsch; R Bader; N Bleese; A Greinacher; C Löwer; K Madlener; G Müller-Berghaus
Journal: Eur J Cardiothorac Surg Date: 1996 Impact factor: 4.191

2. Thrombosis during the use of the heparinoid Organon 10172 in a patient with heparin-induced thrombocytopenia.

Authors: S R Insler; E J Kraenzler; J R Bartholomew; K Kottke-Marchant; B Lytle; N J Starr
Journal: Anesthesiology Date: 1997-02 Impact factor: 7.892

Review 3. Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitor.

Authors: M J Hursting; K L Alford; J C Becker; R L Brooks; J L Joffrion; G D Knappenberger; P W Kogan; T P Kogan; A A McKinney; R P Schwarz
Journal: Semin Thromb Hemost Date: 1997 Impact factor: 4.180

4. Failure of current strategies in the prevention of thrombosis in patients with heparin-induced thrombocytopenia: a clinician's perspective.

Authors: D E Wallis; B E Lewis; J M Walenga
Journal: Semin Thromb Hemost Date: 1999 Impact factor: 4.180

5. Dermatan sulphate in heparin-induced thrombocytopenia.

Authors: G Agnelli; A Iorio; V de Angelis; G G Nenci
Journal: Lancet Date: 1994-11-05 Impact factor: 79.321

6. Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance.

Authors: P Eichler; H J Friesen; N Lubenow; B Jaeger; A Greinacher
Journal: Blood Date: 2000-10-01 Impact factor: 22.113

7. Pregnancy complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172).

Authors: A Greinacher; T Eckhardt; J Mussmann; C Mueller-Eckhardt
Journal: Thromb Res Date: 1993-07-15 Impact factor: 3.944

8. Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172)

Authors: H N Magnani
Journal: Thromb Haemost Date: 1993-10-18 Impact factor: 5.249

9. Recombinant hirudin: clinical pharmacology and potential applications in nephrology.

Authors: R Vanholder; A Dhondt
Journal: BioDrugs Date: 1999-06 Impact factor: 5.807

10. Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia.

Authors: F Schiele; A Vuillemenot; P Kramarz; Y Kieffer; T Anguenot; Y Bernard; J P Bassand
Journal: Am J Hematol Date: 1995-09 Impact factor: 10.047

3 in total

Review 1. Laboratory diagnosis of heparin-induced thrombocytopenia and monitoring of alternative anticoagulants.

Authors: Albrecht Leo; Susanne Winteroll
Journal: Clin Diagn Lab Immunol Date: 2003-09

2. Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee.

Authors: E Magnus Ohman; Christopher B Granger; Lawrence Rice; Charles S Abrams; Richard C Becker; Peter B Berger; Neal S Kleiman; David Moliterno; Stephan Moll; Jo E Rodgers; Stephen S Steinhubl; Victor F Tapson; Peter Sinnaeve; Kevin J Anstrom
Journal: J Thromb Thrombolysis Date: 2005-02 Impact factor: 2.300

Review 3. Thrombin inhibitors from different animals.

Authors: A M Tanaka-Azevedo; K Morais-Zani; R J S Torquato; A S Tanaka
Journal: J Biomed Biotechnol Date: 2010-10-04

3 in total